Synthetic Biology Market

An interdisciplinary field which includes the application of engineering principles to biology is known as synthetic biology. Relatively new as compared to other disciplines of Science and Technology, its main objective is to (re-)design and fabricates such biological components and systems which do not already present in the natural world. To ensure speedy manufacture of modified DNA sequences, and their assembly into two genomes, researchers integrate a chemical synthesis of DNA with better knowledge of genomics. The rising demand for synthetic biology from Biotechnological and Pharmaceutical companies for research and development purposes which contributes to the growth of the synthetic biology market. The application of synthetic biology methods in drug discovery and development also acts as a growth driver for the global synthetic biology market. Furthermore, the investments made by the governments and several corporate organizations in the science and technology field for the discovery of drugs and synthetic biological products, specifically for the development of successful vaccinations to COVID-19 are offering to be a key driver for the growth of synthetic biology market. Moreover, the increasing demand for bio-fuel as a result of global energy crisis, exhaustion of fossil fuels and rising pollution will further favor the synthetic biology market growth. Latest advancements in synthetic biology are paving the way for fourth-generation bio-fuels production, where particularly engineered microorganism/crops will act as feedstock material. Increased per capita energy consumption across the world due to the rapid industrialization with an increase in global population is projected to propel synthetic biology applications across energy sector. However, the dearth of predictability in biology which eventually results in a risk of failure of research and experiments may hamper market growth.

In addition, the rising concern associated to food security with increasing population, changing climate and environmental stress will also fuel the market demand. The major focus of synthetic biology is to fulfill sustainable agricultural practices which allow minimum use of chemical fertilizers and pesticides coupled with increased yield. Factors such as food production with improved shelf life, higher and customized nutritional or medicinal value will boost synthetic biology applications across food and agricultural sector. Increasing use of artificial intelligence, machine learning, and big data for clinical research on bio-systems modeling, chassis development, and genome mining can create an opportunity for the growth of the synthetic biology market in the forecast period.

The global Synthetic Biology Market is segregated on the basis of Products as Synthetic DNA, Synthetic Oligos, Synthetic Genes, Software Tools, Chassis Organisms, Synthetic Clones and Synthetic Cells. Based on Technology the global Synthetic Biology Market is segmented in Nucleotide Synthesis & Sequencing, Bioinformatics, Microfluidics and Genetic Engineering. Based on Application the global Synthetic Biology Market is segmented in Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplastics and Others.

The global Synthetic Biology Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Synthetic Biology Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

Agilent Technologies, Creative Enzymes, Cyrus Biotechnology, Eurofins Scientific and Integrated DNA Technologies and others are among the major players in the global Synthetic Biology Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In March 2020, Zymergen Inc., a California based material innovation company, acquiring enEvolv, Inc. This acquisition has resulted in Zymergen accelerating its delivery of high performing, sustainable products to its customers, besides further bonding the Zymergen’s leadership position in the bio-manufacturing space.
• In 2019, Thermo Fisher Scientific Inc., the world leading company in serving science, officially inaugurated its new $90 million viral vector CDMO (contract development and manufacturing organization) site in Lexington, Mass. The 50,000-square-foot facility will include more than 200 jobs and help the development, testing and manufacture of viral vectors, which are vital to advancing new life-saving gene and cell therapies worldwide.
• In February 2021, Merck collaborated with BioNTech (Germany) to provide lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).

The global Synthetic Biology Market has been segmented as below:

Synthetic Biology Market, By Products

• Synthetic DNA
• Synthetic Oligos
• Synthetic Genes
• Software Tools
• Chassis Organisms
• Synthetic Clones
• Synthetic Cells

Synthetic Biology Market, By Technology

• Nucleotide Synthesis And Sequencing
• Bioinformatics
• Microfluidics
• Genetic Engineering

Synthetic Biology Market, By Application

• Pharmaceuticals & Diagnostics
• Chemicals
• Biofuels
• Bioplastics
• Others

Synthetic Biology Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Synthetic Biology Market, By Company

• Agilent Technologies
• Creative Enzymes
• Cyrus Biotechnology
• Eurofins Scientific
• Integrated DNA Technologies
• Amyris
• Arzeda
• Atum
• Codexis
• GenScript
• Ginkgo Bioworks
• Merck KGaA
• New England Biolab
• Novozymes
• Precigen
• Synthego
• Synthetic Genomics (SGI)
• Teselagen
• Thermo Fisher Scientific
• Twist Bioscience

The report covers the below scope:

• Global Synthetic Biology Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Synthetic Biology Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Synthetic Biology Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Synthetic Biology Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Synthetic Biology Market share. Major industry players with significant revenue share include Agilent Technologies, Creative Enzymes, Cyrus Biotechnology, Eurofins Scientific and Integrated DNA Technologies and others.

Why to Buy this Report:

• Gain detailed insights on the Synthetic Biology industry trends
• Find complete analysis on the market status
• Identify the Synthetic Biology Market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement

1.      Introduction

1.1.       Key Points

1.2.      Report Description

1.3.      Markets Covered

1.4.      Stakeholders

2.     Research Methodology

2.1.      Research Scope

2.2.     Research Methodology

2.2.1.     Market Research Process

2.2.2.    Research Methodology

2.2.2.1.           Secondary Research

2.2.2.2.          Primary Research

2.2.2.3.          Models for Estimation

2.3.     Market Size Estimation

2.3.1.     Bottom-Up Approach

2.3.2.    Top-Down Approach

3.     Executive Summary

4.    Market Overview

4.1.      Introduction

4.2.     Drivers

4.3.     Restraints

4.4.     Opportunities

4.5.     Challenges

5.     Synthetic Biology Market, By Products

5.1.      Key Points

5.2.  Synthetic DNA

5.3.  Synthetic Oligos

5.4.  Synthetic Genes

5.5.  Software Tools

5.6.  Chassis Organisms

5.7.  Synthetic Clones

5.8. Synthetic Cells

6.    Synthetic Biology Market, By Technology

6.1.      Key Points

6.2. Nucleotide Synthesis And Sequencing

6.3. Bioinformatics

6.4. Microfluidics

6.5.  Genetic Engineering

7.     Synthetic Biology Market, By Application

7.1.      Key Points

7.2.  Pharmaceuticals & Diagnostics

7.3.  Chemicals

7.4.  Biofuels

7.5.  Bioplastics

7.6.  Others

8.    Competitive Landscape

8.1.      Introduction

8.2.     Start-up companies- Synthetic Biology Market

8.3.     Recent Developments

8.3.1.     Mergers & Acquisitions

8.3.2.    New Product Developments

8.3.3.    Portfolio/Production Capacity Expansions

8.3.4.    Joint Ventures, Collaborations, Partnerships & Agreements

8.3.5.    Others

9.    Company Profile

9.1.  Agilent Technologies

9.2. Creative Enzymes

9.3. Cyrus Biotechnology

9.4. Eurofins Scientific

9.5.  Integrated DNA Technologies

9.6. Amyris

9.7.  Arzeda

9.8. Atum

9.9. Codexis

9.10.    GenScript

9.11.      Ginkgo Bioworks

9.12.    Merck KGaA

9.13.     New England Biolab

9.14.    Novozymes

9.15.     Precigen

9.16.    Synthego

9.17.     Synthetic Genomics (SGI)

9.18.    Teselagen

9.19.    Thermo Fisher Scientific

9.20.   Twist Bioscience